Advertisement
Canada markets close in 3 hours 12 minutes
  • S&P/TSX

    22,039.93
    +167.97 (+0.77%)
     
  • S&P 500

    5,070.94
    +60.34 (+1.20%)
     
  • DOW

    38,498.69
    +258.71 (+0.68%)
     
  • CAD/USD

    0.7316
    +0.0015 (+0.20%)
     
  • CRUDE OIL

    83.01
    +1.11 (+1.36%)
     
  • Bitcoin CAD

    91,196.90
    +879.53 (+0.97%)
     
  • CMC Crypto 200

    1,435.12
    +20.36 (+1.44%)
     
  • GOLD FUTURES

    2,342.10
    -4.30 (-0.18%)
     
  • RUSSELL 2000

    2,002.71
    +35.24 (+1.79%)
     
  • 10-Yr Bond

    4.5840
    -0.0390 (-0.84%)
     
  • NASDAQ

    15,691.12
    +239.81 (+1.55%)
     
  • VOLATILITY

    16.28
    -0.66 (-3.90%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     

Boralex (TSE:BLX) shareholder returns have been decent, earning 83% in 5 years

Boralex Inc. (TSE:BLX) shareholders might be concerned after seeing the share price drop 23% in the last quarter. But that doesn't change the fact that the returns over the last five years have been pleasing. After all, the share price is up a market-beating 63% in that time.

The past week has proven to be lucrative for Boralex investors, so let's see if fundamentals drove the company's five-year performance.

View our latest analysis for Boralex

We don't think that Boralex's modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. As a general rule, we think this kind of company is more comparable to loss-making stocks, since the actual profit is so low. For shareholders to have confidence a company will grow profits significantly, it must grow revenue.

ADVERTISEMENT

In the last 5 years Boralex saw its revenue grow at 12% per year. That's a pretty good long term growth rate. While the share price has beat the market, compounding at 10% yearly, over five years, there's certainly some potential that the market hasn't fully considered the growth track record. The key question is whether revenue growth will slow down, and if so, how quickly. There's no doubt that it can be difficult to value pre-profit companies.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
earnings-and-revenue-growth

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. This free report showing analyst forecasts should help you form a view on Boralex

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Boralex's TSR for the last 5 years was 83%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

It's good to see that Boralex has rewarded shareholders with a total shareholder return of 7.4% in the last twelve months. And that does include the dividend. However, the TSR over five years, coming in at 13% per year, is even more impressive. The pessimistic view would be that be that the stock has its best days behind it, but on the other hand the price might simply be moderating while the business itself continues to execute. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Boralex has 1 warning sign we think you should be aware of.

Of course Boralex may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here